BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34996922)

  • 1. Application of a tungsten apron for occupational radiation exposure in nursing care of children with neuroblastoma during
    Taniguchi Y; Wakabayashi H; Yoneyama H; Chen Z; Morino K; Otosaki A; Yamada M; Inaki A; Kayano D; Kinuya S
    Sci Rep; 2022 Jan; 12(1):47. PubMed ID: 34996922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation exposure in nurses during care of
    Taniguchi Y; Wakabayashi H; Inaki A; Kayano D; Yamada M; Kinuya S
    Ann Nucl Med; 2020 Jun; 34(6):441-447. PubMed ID: 32297135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation exposure to family caregivers and nurses of pediatric neuroblastoma patients receiving 131I-metaiodobenzylguanidine (131I-MIBG) therapy.
    Markelewicz RJ; Lorenzen WA; Shusterman S; Grant FD; Fahey FH; Treves ST
    Clin Nucl Med; 2013 Aug; 38(8):604-7. PubMed ID: 23797228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of Administering High-Dose (131) I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined Rooms.
    Chu BP; Horan C; Basu E; Dauer L; Williamson M; Carrasquillo JA; Pandit-Taskar N; Modak S
    Pediatr Blood Cancer; 2016 May; 63(5):801-7. PubMed ID: 26773712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should We Keep the Lead in the Aprons?
    Bartal G; Sailer AM; Vano E
    Tech Vasc Interv Radiol; 2018 Mar; 21(1):2-6. PubMed ID: 29471995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Get the Lead off Our Backs!
    Rees CR; Duncan BWC
    Tech Vasc Interv Radiol; 2018 Mar; 21(1):7-15. PubMed ID: 29472000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Aprons Be Properly Evaluated for Their Protective Quality without In-House Validation?
    Weissenborn M; Heithaus E; Weir V; Onofrio A; Rees C
    J Vasc Interv Radiol; 2016 Dec; 27(12):1933-1935.e2. PubMed ID: 27886959
    [No Abstract]   [Full Text] [Related]  

  • 8. Minimizing nuclear medicine technologist radiation exposure during 131I-MIBG therapy.
    Turpin BK; Morris VR; Lemen L; Weiss BD; Gelfand MJ
    Health Phys; 2013 Feb; 104(2 Suppl 1):S43-6. PubMed ID: 23287519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIGH-DOSE 131I-MIBG THERAPIES IN CHILDREN: FEASIBILITY, PATIENT DOSIMETRY AND RADIATION EXPOSURE TO WORKERS AND FAMILY CAREGIVERS.
    Cougnenc O; Defachelles AS; Carpentier P; Lervat C; Clisant S; Oudoux A; Kolesnikov-Gauthier H
    Radiat Prot Dosimetry; 2017 Apr; 173(4):395-404. PubMed ID: 26940442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric 131I-MIBG Therapy for Neuroblastoma: Whole-Body 131I-MIBG Clearance, Radiation Doses to Patients, Family Caregivers, Medical Staff, and Radiation Safety Measures.
    Willegaignon J; Crema KP; Oliveira NC; Pelissoni RA; Coura-Filho GB; Sapienza MT; Buchpiguel CA
    Clin Nucl Med; 2018 Aug; 43(8):572-578. PubMed ID: 29916922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose rates in nuclear medicine and the effectiveness of lead aprons: updating the department's knowledge on old and new procedures.
    Young AM
    Nucl Med Commun; 2013 Mar; 34(3):254-64. PubMed ID: 23353888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of dose savings of lead and lightweight aprons for shielding of 99m-Technetium radiation.
    Warren-Forward H; Cardew P; Smith B; Clack L; McWhirter K; Johnson S; Wessel K
    Radiat Prot Dosimetry; 2007; 124(2):89-96. PubMed ID: 17525062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Not all lightweight lead aprons and thyroid shields are alike.
    Fakhoury E; Provencher JA; Subramaniam R; Finlay DJ
    J Vasc Surg; 2019 Jul; 70(1):246-250. PubMed ID: 30292602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of an additional lead shielding device in reducing occupational radiation exposure during interventional endoscopic procedures: An observational study.
    Yamada R; Saimyo Y; Tanaka K; Hattori A; Umeda Y; Kuroda N; Tsuboi J; Hamada Y; Takei Y
    Medicine (Baltimore); 2020 Aug; 99(34):e21831. PubMed ID: 32846829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient dosimetry after 131I-MIBG therapy for neuroblastoma and carcinoid tumours.
    Monsieurs MA; Thierens HM; Vral A; Brans B; De Ridder L; Dierckx RA
    Nucl Med Commun; 2001 Apr; 22(4):367-74. PubMed ID: 11338046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiation protection in interventional radiology].
    Adamus R; Loose R; Wucherer M; Uder M; Galster M
    Radiologe; 2016 Mar; 56(3):275-81. PubMed ID: 26913507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of Gamma Radiation Using ClearView Radiation ShieldingTM in Nuclear Power Plants, Hospitals and Radiopharmacies.
    Bakshi J; Chu BP
    Health Phys; 2020 Dec; 119(6):776-785. PubMed ID: 32897986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Don't be Caught Half-dressed When Working with Radiation.
    Yu C
    Cardiovasc Intervent Radiol; 2020 Mar; 43(3):369-375. PubMed ID: 31844952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel comprehensive radiation shielding system eliminates need for personal lead aprons in the catheterization laboratory.
    Rabah M; Allen S; Abbas AE; Dixon S
    Catheter Cardiovasc Interv; 2023 Jan; 101(1):79-86. PubMed ID: 36453459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying the radiation exposure of nursing staff delivering hyperbaric oxygen therapy to grade IV neuroblastoma patients post 131I-MIBG therapy.
    Melbourne GJ; Lehm JP
    Eur J Nucl Med; 2000 Nov; 27(11):1732-3. PubMed ID: 11105832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.